Skip to main content

A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J.S.; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Tatjana

Authors

Guy Pratt

Christina Yap

Ceri Oldreive

Daniel Slade

Rebecca Bishop

Mike Griffiths

Martin J.S. Dyer

Chris Fegan

David Oscier

Andrew Pettitt

Estella Matutes

Stephen Devereux

Profile Image

Dr David Allsup D.J.Allsup@hull.ac.uk
Senior Lecturer in Haematology and Honorary Consultant

Adrian Bloor

Peter Hillmen

George Follows

Simon Rule

Paul Moss

Tatjana Stankovic



Journal Article Type Article
Publication Date 2018-08
Journal British Journal of Haematology
Print ISSN 0007-1048
Electronic ISSN 1365-2141
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 182
Issue 3
Pages 429-433
APA6 Citation Pratt, G., Yap, C., Oldreive, C., Slade, D., Bishop, R., Griffiths, M., …Stankovic, T. (2018). A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. British journal of haematology, 182(3), 429-433. https://doi.org/10.1111/bjh.14793
DOI https://doi.org/10.1111/bjh.14793
Keywords Hematology
Publisher URL https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14793
Related Public URLs https://research.birmingham.ac.uk/portal/en/publications/a-multicentre-phase-i-trial-of-the-parp-inhibitor-olaparib-in-patients-with-relapsed-chronic-lymphocytic-leukaemia-tprolymphocytic-leukaemia-or-mantle-cell-lymphoma(c4e32a7c-b830-4da6-9706-617523100

Files





You might also like



Downloadable Citations

;